Roche Expands Hybrid Fleet to 242

9 April 2007

Roche has expanded the number of hybrids in its pharmaceutical sales fleet to a total of 242 vehicles as of the end of 2006.

Approximately 15% of Roche’s sales representatives now drive company-owned hybrid vehicles—a number that is expected to grow with each semi-annual buying cycle.

Roche began its hybrid-car program in July 2004 by replacing 20 conventional gasoline-powered vehicles with Toyota Prius and Ford Escape gas-electric hybrids. Roche is committed to increasing its use of the Ford Escape and Toyota Prius hybrids and to expanding the selection of fuel-efficient vehicles throughout its fleet.